Challenges towards the realization of individualized cancer vaccines

Nat Biomed Eng. 2018 Aug;2(8):566-569. doi: 10.1038/s41551-018-0266-2.

Özlem Türeci¹, Martin Löwer², Barbara Schrörs², Maren Lang³, Arbel Tadmor², Ugur Sahin^{4

5

6}

¹ Cluster for Individualized Immune Intervention (CI3), Mainz, Germany.
² TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.
³ Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.
⁴ TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany. [email protected].
⁵ Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany. [email protected].
⁶ University Medical Center of the Johannes Gutenberg University, Mainz, Germany. [email protected].

No abstract available

MeSH terms